Prostate cancer patients receiving androgen deprivation therapy Cancer Malignant neoplasm of prostate
Conditions
Interventions
The intervention will consist of two components, a dietary intervention and a moderate physical activity intervention.
Dietary modification: The intervention group will meet individua
Sponsors
Belfast Health and Social Care Trust (UK)
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Histologically proven adenocarcinoma of prostate 2. Commencing Lutenising Hormone Releasing Hormone Agonist (LHRHa) therapy for at least 6 months OR already being treated with LHRHa and planned to continue for at least a further 6 months 3. No age limit
Exclusion criteria
Exclusion criteria: 1. Co-morbid condition that limits physical activity such as severe cardiac disease, recent myocardial infarction, severe asthma or breathlessness, uncontrolled hypertension (blood pressure >160/95 mm/Hg) or severe pain 2. Medical conditions that requires a reduced fruit and vegetable diet (e.g. kidney failure) 3. Life expectancy of less than 2 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Body Composition: Anthropometric measurement at baseline, mid-time (3 months) and end (6 months) 2. Fatigue: Self administrated Fatigue Severity Scale (FSS) questionnaire at baseline, mid-time (3 months) and end (6 months) 3. Quality of life: Self administrated Functional Assessment of Cancer Therapy-General (FACT-G) and Functional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire at baseline, mid-time (3 months) and end (6 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| The feasibility of dietary and physical activity intervention will be assessed by drop-out and effectiveness of intervention at the end of intervention. | — |
Countries
Northern Ireland, United Kingdom
Outcome results
None listed